News Lilly loses bid to nix $184m Medicaid fraud penalty Lilly has lost an appeal in a whistleblower lawsuit that alleged it had defrauded Medicaid by underpaying rebates.
News Texas suit claims Lilly bribed providers to prescribe drugs Eli Lilly has been accused of giving illegal inducements to encourage medical providers in Texas to prescribe its medicines.
News Trump gives pharma ultimatum on most favoured nation pricing President Trump has given 17 pharma companies until 29th September to commit to providing lower prices "to every single Medicaid patient."
News Trump signs Medicaid-slashing budget into law Trump's One Big Beautiful Bill Act is signed into law, and commentators are gauging its impact on healthcare insurance coverage.
News Update: Trump 'will tie US drug prices to other countries' President Donald Trump said he will sign an order today to cut prescription drug prices in the US to the level paid by other comparable countries.
News Spectre of 'favoured nation' pricing manifests again in US President Trump is rumoured to be resurrecting a policy that would see drug prices offered to federal programmes tied to those offered overseas.
Oncology On looking to a future multiomics approach for CDx, with Jan... The pharmaphorum podcast caught up with Jane Li, VP and general manager for companion diagnostics at Thermo Fisher Scientific, following ESMO 2026.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.